Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment


Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

The pharmaceutical company behind a drug that’s been approved by the Food and Drug Administration for emergency use for covid-19 patients announced today the drug will cost $3,120 per typical treatment course for individuals with private insurance plans.

Read more...


Tags: Science, Food And Drug Administration, Gilead, Coronavirus, Covid 19, Sars Cov 2, Remdesivir

Source:  https://gizmodo.com/gilead-to-charge-3-120-per-patient-for-typical-covid-1-1844208210




Related:
April 29, 2020 at 3:09 PM FDA to Allow Emergency Use of Experimental Drug as Studies Show Mixed Results for Treating Covid-19
April 24, 2020 at 4:13 PM There Probably Won’t Be a Miracle Cure for Covid-19
March 25, 2020 at 10:50 PM Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug
March 16, 2020 at 1:51 PM First human trial for coronavirus vaccine begins